(BGH) Barings Global Short - Ratings and Ratios
Exchange: NYSE • Country: USA • Currency: USD • Type: Fund • ISIN: US06760L1008
BGH: High-Yield Bonds, Fixed Income
The Barings Global Short Duration High Yield Fund (NYSE:BGH) is a high-yield bond fund originating from the USA, providing investors with exposure to a diversified portfolio of short-duration, high-yield debt securities. As a closed-end fund, BGH is designed to generate regular income and potentially lower volatility compared to longer-duration high-yield bond funds.
From a technical analysis perspective, the funds price is currently at $14.66, indicating a bullish trend as it is above its 20-day Simple Moving Average (SMA) of $14.19 and slightly above its 50-day SMA of $14.54. However, it remains below its 200-day SMA of $14.71, suggesting a potential resistance level. The Average True Range (ATR) of 0.32, or 2.17%, indicates moderate volatility. Given the current price action and technical indicators, a potential trading range could be between $14.00 and $15.00, with a breakout above $15.00 potentially targeting the 52-week high of $15.74.
Fundamentally, the fund has $219.50 million in Assets Under Management (AUM), which is a relatively manageable size, allowing for flexibility in portfolio management. The high-yield bond market, in which BGH operates, is influenced by factors such as interest rates, credit spreads, and overall economic conditions. As a short-duration high-yield fund, BGH is positioned to be less sensitive to interest rate changes but remains exposed to credit risk.
Combining technical and fundamental insights, a forecast for BGH could be constructed. Assuming a stable economic environment with moderate growth and stable interest rates, the demand for high-yield bonds could remain robust, supporting the funds income generation capabilities. Technically, if the funds price can break through the $15.00 resistance level, it may attract further buying interest, potentially driving the price towards the 52-week high of $15.74. Conversely, a decline below $14.00 could signal a downturn, targeting the 52-week low of $12.70. Therefore, a potential investment strategy could involve monitoring the funds price action around the $14.00 to $15.00 range for potential trading opportunities.
Additional Sources for BGH Fund
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
BGH Fund Overview
Market Cap in USD | 220m |
Style | High Yield Bond |
TER | 1.98% |
IPO / Inception | 2012-10-25 |
BGH Fund Ratings
Growth Rating | 69.3 |
Fundamental | - |
Dividend Rating | 79.2 |
Rel. Strength | 19.8 |
Analysts | - |
Fair Price Momentum | 15.56 USD |
Fair Price DCF | - |
BGH Dividends
Dividend Yield 12m | 12.51% |
Yield on Cost 5y | 24.54% |
Annual Growth 5y | 1.78% |
Payout Consistency | 85.9% |
Payout Ratio | % |
BGH Growth Ratios
Growth Correlation 3m | -49.6% |
Growth Correlation 12m | 62% |
Growth Correlation 5y | 71.9% |
CAGR 5y | 14.68% |
CAGR/Max DD 5y | 0.55 |
Sharpe Ratio 12m | 1.89 |
Alpha | 8.28 |
Beta | 0.584 |
Volatility | 11.43% |
Current Volume | 65.4k |
Average Volume 20d | 80.9k |
As of June 02, 2025, the stock is trading at USD 14.80 with a total of 65,374 shares traded.
Over the past week, the price has changed by +1.30%, over one month by +4.44%, over three months by -4.60% and over the past year by +17.16%.
Yes. Based on ValueRay´s Analyses, Barings Global Short (NYSE:BGH) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 69.29 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BGH is around 15.56 USD . This means that BGH is currently overvalued and has a potential downside of 5.14%.
Barings Global Short has no consensus analysts rating.
According to our own proprietary Forecast Model, BGH Barings Global Short will be worth about 17.6 in June 2026. The stock is currently trading at 14.80. This means that the stock has a potential upside of +18.72%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 17.6 | 18.7% |